Immunoglobulin free light chains and solitary plasmacytoma of bone - Wikidata - awgldk - TriplyDB

Immunoglobulin free light chains and solitary plasmacytoma of bone

Immunoglobulin free light chains and solitary plasmacytoma of bone

http://www.wikidata.org/entity/Q24685868

about

Appraisal of immunoglobulin free light chain as a marker of response Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system Lymphoproliferative disease-related mixed cryoglobulinemia treated with rituximab and prednisolone Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint.Outcomes of patients with POEMS syndrome treated initially with radiation.Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.Solitary bone plasmacytomas need to flow Robert Arthur Kyle, MD: a conversation with the editor.Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.The evolving use of serum free light chain assays in haematology.Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.Progression in smoldering Waldenstrom macroglobulinemia: long-term results.Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy.Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004.Solitary Extramedullary Plasmacytoma of the Maxillary Sinus, Progressing to Smoldering Multiple Myeloma with Multifocal Skeletal Involvement, which Resolved Completely Following Chemotherapy Alone Prognostic significance of serum free light chains in chronic lymphocytic leukemia.The Evolution of Prognostic Factors in Multiple Myeloma.Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias.Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy.Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review.Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma.Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions.Serum free light chains in patients with HIV infection: their association with markers of disease severity and antiretroviral use.Back pain caused by a solitary plasmacytoma of bone.Rapid progression of solitary plasmacytoma to multiple myeloma in lumbar vertebra.Screening panels for monoclonal gammopathies: time to change Bcl-2 expression is associated with poor prognosis of solitary plasmacytoma of bone.Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.Solitary Plasmacytoma.18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma.Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients.Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders.

P2860

Q24624398-56A23A97-EBD8-4900-B96E-9D252839A3E3 Q24647620-E5E6532B-F7F6-4128-8B5B-C364D06848DE Q24650785-745FA65D-7B8D-474A-BA39-909C67E18CE8 Q24653434-3ACE5C40-688A-4687-9D0B-A5632792F1A5 Q33628235-D0B011CD-DD80-4815-AD00-F74B6FBB897D Q33652326-A367AC90-9D43-4448-91C2-70160CC27974 Q33794285-08142EA2-10E0-4769-ADB3-3553B9EB2CF1 Q33988217-3A7F6C8B-4A0F-459D-9F5E-6429E60E83AE Q34077757-D420743B-0313-403B-89D7-D81A74E0F666 Q34145491-F874E954-17A6-4DD8-B9F7-70C4E16ACB3C Q34615704-F28D9507-7F83-4ED2-B3C0-F7A9E54E7881 Q34758218-F363092A-4FF9-4502-BC68-6B56EF46BC6E Q34866311-A7045525-224E-492A-AF53-6444BE4553C4 Q35212377-CD7FF7E6-B822-4966-974D-407E04A52FA9 Q35995219-887D25FE-EEBF-4B0E-8FC5-5A47D5D796D7 Q36137449-137FE1AE-27E8-4EB5-9FD8-F4AC67DC7C2C Q36205711-E67EFCB2-77DE-4FF5-8F1F-E5145BFD7C4A Q36572310-965A702E-C540-4F56-B153-18AA35AF3A1B Q36658320-AC14BA81-6DD7-4154-AA5F-7EBFDF7D15FB Q37029350-7EC1972E-CE67-4C8B-A64B-B2EBAD4598A6 Q37048573-95A63C3E-54E0-49F5-8036-ABAFFCFDDF25 Q37316098-7D8E03C3-F372-4315-83EE-B772966B0900 Q37683483-C56F9FF4-A524-47E9-9FBA-1082812DA1F6 Q37821496-678B7096-3299-4385-9363-DC568A76F3F9 Q37857784-8849AF8C-5AC9-44A4-A64A-25F6A05EF478 Q38010146-789B3DE4-DE6D-4224-A1E8-8AE2E3D75B27 Q38168869-B5F66E6E-D287-400C-93D2-E3FD184A4FBE Q39531260-EC46DA69-3B2A-4A10-B41D-A4AF6E73C177 Q39932145-1A1D98DF-0E67-4B47-8DEF-EED08D4639C0 Q41632306-6A12F97D-3AC1-4FAA-9449-DA91DAF01C8C Q41860190-9D229916-48BF-4481-9FFB-B968EA9E7F0E Q42012860-2F140D14-72A9-4E2B-A746-21255D4474C0 Q42098619-E6A7D032-862F-4AE0-BD41-F50BAB8F8C80 Q44080067-09FD7835-BCE4-49D5-A5C4-23657F263202 Q44944338-7BB0656A-1FA0-425B-8FA4-3248955B19C6 Q48232766-39055B18-B7BA-45AE-BB45-FABC9F481900 Q50144450-833FBC20-5F34-409F-A193-2CE44C266F4D Q50500122-CE124949-5A57-4BBC-9041-EC23F31FA2B3 Q53081939-DAB6F915-A050-4638-AA1B-63010A1ED6FC Q53494635-0CAE2CF1-F4DF-4747-90C4-261C709F4324

P2860

Immunoglobulin free light chains and solitary plasmacytoma of bone

http://www.wikidata.org/entity/Q24685868

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Immunoglobulin free light chains and solitary plasmacytoma of bone

@ast

Immunoglobulin free light chains and solitary plasmacytoma of bone

@en

Immunoglobulin free light chains and solitary plasmacytoma of bone

@nl

type

label

Immunoglobulin free light chains and solitary plasmacytoma of bone

@ast

Immunoglobulin free light chains and solitary plasmacytoma of bone

@en

Immunoglobulin free light chains and solitary plasmacytoma of bone

@nl

prefLabel

Immunoglobulin free light chains and solitary plasmacytoma of bone

@ast

Immunoglobulin free light chains and solitary plasmacytoma of bone

@en

Immunoglobulin free light chains and solitary plasmacytoma of bone

@nl

P1433

Q24685868-D3EF0BFD-157B-4810-A63C-AB101EF994B2

P1476

Q24685868-12EE245F-7C6D-4179-B9BE-421471FF3023

P2093

Q24685868-582C2C98-9840-4A14-A957-47CCCBC30F0B

Q24685868-64FA9DA6-A316-47CA-89D1-AB356D036737

Q24685868-7B20FB21-1AC1-492E-B1AC-FE6AC397A414

Q24685868-DAD52800-FAF1-4521-899C-1FD363F2E5B5

Q24685868-EDA3245B-D6CE-41AB-83B8-EAE23974A441

Q24685868-FA37A415-3953-413E-B08E-FFB977DC131D

P2860

Q24685868-19B915D7-0455-46ED-B0AA-BE00B1E8C7C3

Q24685868-1A476B43-C282-4EA7-B760-9310220F0A76

Q24685868-26235BF4-F923-4267-9E3F-6FF623C13EB9

Q24685868-5A8E3468-6EA5-4860-8621-12DB238FCE09

Q24685868-601C3CAE-72DD-4F32-8798-9F8FEDA78156

Q24685868-A10B156D-805F-4CAE-85DF-C70BB99AE712

Q24685868-A5AAC58B-EFB2-4976-88A9-2B0F1CDD81C3

Q24685868-C2474BFF-0C19-49E3-BA78-007CED06A00B

Q24685868-C255CF3B-CA2F-4641-B7C1-FCBC8E29B9B2

Q24685868-D6A98747-34E3-42B1-8A95-AE04B5FAD5FD

P304

Q24685868-77D67E43-15D8-4B87-8C4C-665AB55B47DE

P31

Q24685868-BE181134-D8E4-45A5-895B-70E56613FBE5

P356

Q24685868-18415342-36B0-47FF-B2F6-2A76CE6683A8

P407

Q24685868-E3A4AD7B-EFA9-4C94-ADA7-3FE558A54577

P433

Q24685868-1B276E0A-A770-4643-ADEF-FCD87B3F2215

P478

Q24685868-676118CB-E4D1-4D33-B1AC-E09EB4621950

P50

Q24685868-28E567E1-7627-4281-8C89-201C86555840

Q24685868-44ABB901-7BC3-484E-B07F-58E9F9BB5F96

Q24685868-7632B89F-C24B-413E-9E81-358DBDFDB0D9

Q24685868-7B678E45-FE8C-4D77-A844-D867E336A928

Q24685868-978D05C8-CFA2-47F9-BB8C-2A477361C5AF

P577

Q24685868-65971697-FA83-4C22-9E99-BFA7C199F4CD

P5875

Q24685868-6C2F40B0-C683-426F-B1AB-2923706D2D27

P698

Q24685868-6D1E1D0E-29B7-43CE-9EFE-876A09A6EA95

P921

Q24685868-4A73C56E-D165-43B9-94D4-8C887FEB766A

P932

Q24685868-BA72BEDF-1B60-4F6B-997F-5DDDBD5D153B

P356

BLOOD-2006-04-015784

P1433

P1476

Immunoglobulin free light chains and solitary plasmacytoma of bone

@en

P2093

Dirk R Larson

http://www.w3.org/2001/XMLSchema#string

Grzegorz S Nowakowski

http://www.w3.org/2001/XMLSchema#string

Jerry A Katzmann

http://www.w3.org/2001/XMLSchema#string

John P Bida

http://www.w3.org/2001/XMLSchema#string

L Joseph Melton

http://www.w3.org/2001/XMLSchema#string

Terry M Therneau

http://www.w3.org/2001/XMLSchema#string

P2860

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

Solitary plasmacytoma of bone and asymptomatic multiple myeloma

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains

Solitary plasmacytoma of bone and extramedullary plasmacytoma.

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

Serum test for assessment of patients with Bence Jones myeloma.

Solitary plasmacytoma of bone: Mayo Clinic experience.

Solitary myeloma: clinical and prognostic features of a review of 114 cases.

Solitary plasmacytoma of bone: treatment, progression, and survival.

Curability of solitary bone plasmacytoma.

P304

1979-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2006-04-015784

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Angela Dispenzieri

S. Vincent Rajkumar

P577

2006-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7042214

http://www.w3.org/2001/XMLSchema#string

P698

16741249

http://www.w3.org/2001/XMLSchema#string

P921

P932

1895544

http://www.w3.org/2001/XMLSchema#string